GATA3 and telomere syndrome: Haraguchi et al. demonstrated GATA3 immunopositivity in approximately 20% of STS cases, correlating with higher grade and worse survival, thereby suggesting a broader oncogenic function of this factor beyond epithelial differentiation [17].